课题基金 / 基金详情

Ionic movement and tolerance to ischemia in congenital heart disease : Sodium movement via the Na^+/H^+ exchange during reoxygenation is a determinant of post-ischemic functional recovery in the rat myocardium

Ionic movement and tolerance to ischemia in congenital heart disease : Sodium movement via the Na^+/H^+ exchange during reoxygenation is a determinant of post-ischemic functional recovery in the rat myocardium
先天性心脏病中的离子运动和缺血耐受性:再氧合过程中通过 Na^ /H^ 交换进行的钠运动是大鼠心肌缺血后功能恢复的决定因素
批准号:
16591383
负责人:
YAMAMOTO Hiroshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

YAMAMOTO Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
目的:为了确定复氧过程中钠离子运动是否是缺血后心功能恢复的决定因素,我们检测了i)再灌注或复氧过程中Na^+/H^+交换抑制对缺血后心功能恢复的影响,以及ii)Na+/HCO_3^-协同转运蛋白参与钠离子运动。用碳酸氢盐缓冲液对离体大鼠心脏进行Langendorff灌流,并在常温(37 ℃)下进行20分钟的全脑缺血,然后在常温(37℃)下进行再灌注。i)在再灌注的前10分钟(方案I)或缺氧再灌注5分钟后10分钟(方案II)给予100 μM二甲基阿米洛利(DMA)。ii)在再灌注的前10分钟期间使用不含碳酸氢盐的HEPES缓冲液(方案III)。所有的方案随后均进行25分钟的常氧再灌注。i)在方案I和II中,DMA组的左心室发展压(%LVDP)的缺血后恢复显著大于对照组。(方案中分别为68.6± 5.9%和52.0± 6.1%,方案II中分别为66.6± 2.8%和52.0± 5.5%)。在方案III中,无碳酸氢盐组和对照组之间没有差异(分别为35.9±4.9和24.7± 6.7%)。结论:在复氧过程中,通过Na^+/H^+交换的钠离子运动是缺血后心功能恢复的决定因素。Na^+/HCO_3^-协同转运蛋白可能不参与再灌注过程中的钠离子运动。
英文摘要
Objectives : To determine whether or not sodium ion movement during reoxygenation is a determinant of post-ischemic recovery of cardiac function, we examined i) the effect of Na^+/H^+ exchange inhibition during reperfusion or reoxygenation on post-ischemic recovery of cardiac function and ii) the involvement of Na+/HCO_3^-cotransporter in the sodium ion movement.Methods : Isolated rat hearts were Langendorff-perfused with Krebs-Henseleit bicarbonate buffer and subjected to 20 minutes of normothermic (37C) global ischemia followed by normothermic (37℃) reperfusion. i) 100 μM dimethyl amiloride (DMA) was given during the first 10 min of reperfusion (protocol I) or for 10 minutes after 5-minute hypoxic reperfusion (protocol II). ii) a bicarbonate-free HEPES buffer was used during the first 10 minutes of reperfusion (protocol III). All the protocols were then followed by 25 minutes of noromoxic reperfusion.Results : i) In protocols I and II, the post-ischemic recovery of left ventricular developed pressure (%LVDP) was significantly greater in the DMA group than in the control group (68.6±5.9 vs. 52.0±6.1%, respectively in protocol Land 66.6±2.8 vs. 52.0±5.5%, respectively in protocol II). In protocol III, there was no difference between the bicarbonate-free group and the control group (35.9±4.9 vs. 24.7±6.7%, respectively).Conclusions : Sodium ion movement via the Na^+/H^+ exchange during reoxygenation is a determinant of post-ischemic recovery of cardiac function. The Na^+/HCO_3^- cotransporter may not be involved in the sodium ion movement during reperfusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishment of Innovative Method to Create Metal/Semiconductor Junctions in One Piece of Single Walled Carbon Nanotube
  • 批准号:
    16K14236
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.33万
  • 财政年份:
    2016
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
A study on an integrated model of perceived employability: From the viewpoint of international comparison and longitudinal comparison
  • 批准号:
    24530473
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
Development of the human tissue-equivalent phantom for millimeter wave range
  • 批准号:
    24700462
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $1.41万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
Newly Proposal for Chirality Control of Single-Walled Carbon Nanotubes by Resonance Photo-Excitation
  • 批准号:
    24560383
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2012
  • 负责人:
    YAMAMOTO Hiroshi
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李轶
  • 依托单位:
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
  • 批准号:
    82371142
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘君
  • 依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题